Columnist Desiree Lama writes in praise of community and human connections, which make such a difference when living with ...

Children with pediatric-onset MS tend to use more healthcare resources, starting from birth and escalating until their ...

Pro-inflammatory signaling molecules in MS cause problems with the growth and development of myelin-making cells in the brain ...

As aging has her experiencing estrogen loss and her MS, columnist Susan Payrovi evaluates her response to the changes she's ...

MS patients on B-cell depleting therapies are still protected against COVID-19 risk due to greater anti-viral T-cell activity, a study found.

Using disease-modifying therapies in MS tends to reduce the risk of stroke, though effects vary depending on the type of DMT, ...

For columnist Ben Hofmeister, living with MS isn't about viewing the glass as half-full or half-empty, but adopting a blend of outlooks.

Subtle symptoms of MS are often overlooked in patients with minimal disability, but clinical tools can help detect them early ...

While there was more risk, most studies couldn't disentangle the effects of childhood adversity from other factors that may ...

Half of UK MS patients surveyed say they've stayed in jobs that don’t support their needs, and a third are in roles below their skill levels.

Cognitive symptoms, mood disorders, and fatigue manifest differently in relapsing-remitting vs. progressive forms of MS, a ...